Apollon Wealth Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.1K Buy
20,284
+1,500
+8% +$4.25K ﹤0.01% 1541
2026
Q1
$45.5K Hold
18,784
﹤0.01% 1372
2025
Q4
$81.9K Hold
18,784
﹤0.01% 1268
2025
Q3
$78.9K Hold
18,784
﹤0.01% 1278
2025
Q2
$53.9K Hold
18,784
﹤0.01% 1237
2025
Q1
$50.7K Buy
18,784
+1,921
+11% +$7.21K ﹤0.01% 1174
2024
Q4
$39.8K Buy
16,863
+2,857
+20% +$7.6K ﹤0.01% 1177
2024
Q3
$33.2K Sell
14,006
-87
-0.6% -$192 ﹤0.01% 1116
2024
Q2
$27.5K Buy
14,093
+87
+0.6% +$296 ﹤0.01% 1086
2024
Q1
$90.1K Hold
14,006
﹤0.01% 1064
2023
Q4
$196K Buy
+14,006
New +$221K 0.01% 1011

Other funds holding GNLX

Apollon Wealth Management's GNLX Position: Q2 2026 in Review

Apollon Wealth Management increased its Genelux (GNLX) stake by 8% in Q2 2026, buying an estimated $4.25K and bringing the position to 20,284 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1541.

Apollon Wealth Management first reported a position in GNLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $196K in Q4 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Apollon Wealth Management held 20,284 shares of Genelux worth $61.1K as of Q2 2026.
  • Apollon Wealth Management bought 1,500 Genelux shares in Q2 2026, an estimated $4.25K.
  • Genelux made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1541 holding.
  • Apollon Wealth Management first reported a position in Genelux in Q4 2023 and has held it in 11 quarters since.
  • Apollon Wealth Management's Genelux position peaked at $196K in Q4 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.